For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

Supplementary insurance coverage for complementary health services (Yes) 202 55.0 Has a family physician (Yes) 308 83.5 Comorbid anxiety disorder ... reasons 334 89.5 General practitioner 292 ...

It’s hard to know how long anxiety disorders will last when you’re in the thick of them. It was during the mid-2000s that my ...

but subsequent treatment can be widely divergent for a primary anxiety disorder, compared with a secondary anxiety disorder. The overlap between GAD and personality disorder has not been well studied.

The National Institute of Mental Health (NIMH) states the risk factors can vary for each type of anxiety disorder. However, general risk ... often the first line of treatment for separation ...

ITI-1284 is under clinical development by Intra-Cellular Therapies and currently in Phase II for Generalized Anxiety Disorder (GAD).

Psychedelic drug company Mind Medicine Inc. (MindMed) (NASDAQ: MNMD) published its 2025 Investor Presentation this week with ...

Mind Medicine (NASDAQ: MNMD) stock is posting big gains in Tuesday's trading. The biotech company's share price was up 8.7% ...